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Abstract
Background. GPs are daily confronted with mental disorders and psychosomatic problems. The 
Four-Dimensional Symptom Questionnaire (4DSQ), measuring distress, depression, anxiety 
and somatization, was purposively developed for primary care. It has been translated into 12 
languages and is commonly used in several countries. It was translated into French in 2008, by 
forward and backward translation, but it has not been validated for a primary care population.
Aim. This study aimed to establish whether the French 4DSQ measured the same constructs in the 
same way as the original Dutch 4DSQ.
Method. Two samples of French general practice patients were recruited during routine care 
to obtain as much variability as possible. One sample included consecutive patients, from the 
waiting room of rural GPs, over a period of 2 weeks and the other sample included patients with 
suspected psychological problems or unexplained symptoms. This population was compared to a 
matched Dutch sample using confirmatory factor analysis (CFA) and differential item functioning 
(DIF) analysis.
Results. A total of 231 patients, from 15 French GPs, completed the questionnaire (Dutch reference 
group: 231). Mean age was 42.9 years (Dutch: 42.1); females numbered 71% in both samples. The 
multigroup CFA assessed configural invariance of one-factor models per 4DSQ scale. Thirteen of 
the total of 50 items in the 4DSQ, in three scales, were detected with DIF. However, DIF did not 
impact on the scale scores.
Conclusion. French 4DSQ scales have the same latent structures and measure the same traits as 
the original Dutch 4DSQ.
Key words:  Medically unexplained symptoms, mental health, primary care, screening.
Introduction
Self-administered questionnaires are widely used to evaluate mental 
disorders in hospital. For example, the Beck Depression Inventory 
and the Beck Anxiety Inventory are commonly used either for fol-
lowing up patients or for research. They are translated and validated 
in many languages. Unfortunately, these questionnaires received 
4DSQ with DIF analysis 475
little development or validation within primary care. These ques-
tionnaires are actually of limited interest in primary care, as they 
were designed to screen and follow up severe psychiatric disease. 
Few questionnaires were specifically developed for general practice, 
such as the Mini International Neuropsychiatric Interview test for 
depression (1). In general practice, around a third of the consulta-
tions are related to psychological problems, including both ‘classic’ 
psychiatric disorders, subsyndromal and psychosocial problems (2). 
These problems are at the same time very common, and difficult for 
the GP to investigate, as they are often mixed with other symptoms, 
and difficult for the patient to admit to. Use of questionnaires can 
help to detect, evaluate or follow these patients, especially to make 
the distinction between psychiatric disorders and psychosocial prob-
lems. Self-administered questionnaires can be more efficient to use in 
general practice and, in addition, could help the patient to consider 
the psychosocial source of their physical disorders (3). For those rea-
sons, Terluin, a Dutch primary care doctor and researcher, developed 
a questionnaire, the Four-Dimensional Symptom Questionnaire 
(4DSQ), which measures four dimensions of psychological prob-
lems commonly encountered in a GP’s practice: distress, anxiety, 
depression and somatization (4). It helps patient and physician 
to acknowledge psychological distress when they are confronted 
with unexplained symptoms. This 50-item questionnaire has been 
translated into 12 languages and has already had Dutch, Polish 
and English versions validated (5,6). It was translated into French 
using a forward and backward method. However, it is known that 
intended meaning could be lost or influenced by cultural variations 
in the expression of attitudes and emotions. This could give rise to an 
unintended change of meaning within the translated questionnaire. 
We proceeded to a validation process of the French 4DSQ, to ensure 
that it worked in the same way as the original Dutch questionnaire.
Research question
Does the French 4DSQ measure the same constructs in the same way 
as the original Dutch 4DSQ questionnaire? To answer this question, 
we took the approach of assessing measurement equivalence, i.e. the 
equivalence of the measurement models of the Dutch and French 
4DSQ versions. When the French 4DSQ demonstrates equivalence 
with the Dutch 4DSQ, it can be assumed that the validity and reli-
ability of the Dutch 4DSQ will also apply to the French 4DSQ.
Method
Design and participants
Data were obtained from two samples of French General Practice 
patients, drawn from two different parts of France. Both groups 
consisted of adult patients (aged 18–64 years), attending 12 GPs in 
2013. The patients were recruited during routine care. Patients were 
selected using two different methods in order to obtain a wide vari-
ability of responses. In one sample (Group 1), questionnaires were 
given out to consecutive patients by five GPs from rural areas, in their 
waiting room, over a 2-week period. In the other sample (Group 2), 
seven GPs were asked to recruit, preferably, patients with (suspected) 
psychological problems, such as distress, depression or anxiety, or 
medically unexplained symptoms, defined as persistent symptoms 
for which no medical causes were found, such as pain, dizziness and 
gastrointestinal troubles. Each of the GPs in this sample, from urban 
and rural areas, was asked to issue 10 questionnaires. These two 
ways of selecting were chosen on purpose to obtain as wide a vari-
ability as possible. For practical reasons, a nil response could not be 
recorded. The patients were fully informed about the study’s aim. 
Participation was voluntary and patients consented by returning the 
completed questionnaire. Data were immediately anonymized.
For comparison with the French data, 4DSQ data from Dutch 
patients, matched on gender and age (10-year groups), were drawn 
from a large sample of 1114 patients with (suspected) mental health 
problems or medically unexplained symptoms, visiting their GP in a 
primary care health centre in Almere, in the Netherlands. The Dutch 
4DSQ data had been collected during routine care.
The questionnaire
The 4DSQ is a 50-item self-report questionnaire. Those items explore 
four scales: distress, depression, anxiety and somatization. First, 
depression (6 items) and anxiety (12 items) were evaluated from spe-
cific symptoms of depressive and anxiety disorders (4 items). The 16 
items on the distress scale measure the global response to people’s 
stress. The scale evaluates various aspects: associated with work, 
family, life events or psychosocial difficulties of any kind (3 items). 
Somatization is measured by symptoms associated with somatic dis-
tress (16 items). Response choices follow a Likert scale: 0 for ‘no’, 
1 for ‘sometimes’ and 2 for the other categories: ‘regularly’, ‘often’, 
‘very often or constantly’. The item scores are totalled within each 
dimension scale. The interpretation of each score is worked out 
according to validated cut-off points: normal, moderate and severe 
scores. Finally, these scales inform the professional’s decision mak-
ing. The 4DSQ is freely available for non-commercial use at: www.
emgo.nl/researchtools/4dsq.asp.
The first French translation was created in 2008. Two GPs, 
French native speakers, drafted the first French translation, which 
was then back-translated by an independent Dutch native speaker 
and professional translator. Discrepancies between the back transla-
tion and the original Dutch text were resolved by discussion with 
both translators.
Missing item scores were imputed using the response function 
method, provided that no more than half of the item scores of a scale 
were missing (7).
Analyses
First, essential uni-dimensionality was evaluated using multigroup 
confirmatory factor analysis (CFA) as implemented in the R pack-
age ‘lavaan’ (8). We fitted, for each of the 4DSQ scales, one-factor 
models allowing residual correlations between item pairs sharing 
specific content. The item scores were treated as ordered indicators. 
Fit measures indicating adequate fit included a confirmatory fit index 
>0.95, Tucker–Lewis index >0.95 and root mean square error of 
approximation <0.06 (9).
Second, to assess measurement equivalence, we used differential 
item functioning (DIF) analysis (10). DIF analysis examines whether 
an item demonstrates the same ‘function’ across different groups 
(e.g. French and Dutch patients), as evidenced by the item’s relation-
ship to the latent trait (e.g. depression) the item is supposed to be an 
indicator of. The item–trait relationship is expressed in the correla-
tion between item and trait and in the threshold for being endorsed. 
In the absence of DIF, the French items and their original Dutch 
counterpart items possess the same correlations with the underlying 
latent trait and the same thresholds for endorsement. DIF is present 
when different groups (e.g. French and Dutch patients) have differ-
ent probabilities of endorsing the response options of an item, while 
having the same position on the underlying trait that the item is sup-
posed to measure (11). Following the advice of Hambleton (12), we 
used two different methods: the non-parametric Mantel–Haenszel 
(M–H) method (13), as implemented in the statistical program 
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jMetrik (14), and the parametric ordinal logistic regression (OLR) 
method, as implemented in the R package ‘lordif’ (15). DIF was con-
sidered present when, in the M–H analysis, the standardized mean 
difference was >0.1 and P < 0.01 or, in the OLR analysis, the R2 dif-
ference was >0.02 and P < 0.01.
Third, we assessed the impact of DIF on the scale scores. This is 
of greater importance because in research and clinical practice the 
scores are usually interpreted on the scale score level and not on the 
individual item level. The impact of DIF was evaluated by compar-
ing the raw scale scores with item response theory (IRT) scale scores 
produced by Rasch analysis, using the DIF-free items as anchors 
to fit all items and patients on the same scales. The IRT score was 
thus adjusted for the effect of DIF in certain items and reflected the 
true (e.g. DIF-free) trait score. Rasch analysis was performed using 
jMetrik (14).
Results
The French group consisted of 179 primary care patients from 
Group 1 and 52 primary care patients from Group 2 (total n = 231). 
The percentage of females was 71%. The mean age was 42.9 years 
(SD = 11.7). The Dutch reference group consisted of 231 primary 
care patients, 71% of whom were female, and the mean age was 
42.1 years (SD = 11.6). In the French sample, 15% had one or more 
missing item scores; in the Dutch sample, this was the case in 23% 
of the patients. The percentage of missing item scores was very low: 
0.5% in the French sample and 0.7% in the Dutch sample. The miss-
ing scores were successfully imputed.
The results of the multigroup CFA are presented in Table 1. All 
4DSQ scales demonstrated adequate fit of the one-factor model. 
Residual correlations, to improve the model fit, were allowed for 
two item pairs of the distress scale and two item pairs and one item 
triplet of the somatization scale. These items arguably shared com-
mon content (see the footnote to Table 1).
Table 2 presents the results of the DIF analyses. The distress scale 
turned out to be free of DIF. A total of 13 items were flagged for DIF 
by either method. The M–H method detected seven DIF items and 
the OLR method detected nine items. Only three DIF items were 
detected by both methods. Seven items were found to be less severe 
for French patients. That means that French patients had a lower 
threshold than Dutch patients for endorsing these items. As an illus-
tration, Figure 1 (left panel) shows the ‘item response function’ of 
Item 3, an item of the somatization scale. French patients endorsed 
this item at a lower level of somatization than Dutch patients. French 
patients needed less severe somatization to endorse this item than 
Dutch patients. Apparently, ‘des malaises’ was a less severe symp-
tom of somatization than ‘flauw vallen’ (in English: ‘fainting’). On 
the other hand, six items appeared to be more severe for French 
patients than for Dutch patients. This means that the item repre-
sented a more severe symptom. Figure 1 (right panel) shows an item 
that was more severe for French patients. Apparently, ‘comme ça, un 
saisissement soudain’ represented a more severe level of anxiety than 
‘zomaar plotseling schrikken’ (in English: ‘sudden fright for no rea-
son’). An item that is less severe might lead to higher scores than can 
be explained by the true level of somatization or anxiety, whereas an 
item that is more severe can lead to a lower score.
The Rasch analyses revealed that the DIF-laden French items gen-
erally fitted the Rasch scale model equally well or even better than 
the Dutch counterpart items (data not shown). Figure 2 presents the 
graphical comparison of the raw scale scores with the DIF-free IRT 
score. The vertical distance between the group-specific curves proves 
the impact of DIF. Figure 2 demonstrates that the impact of DIF was 
limited to (very) high levels of depression and anxiety. In terms of the 
interpretation of the scores in relation to cut-off scores, the impact 
of DIF was negligible. It is probable that the DIF in certain opposing 
items cancelled each other out within the scale.
Discussion
Our results demonstrate that the French 4DSQ scales have the same 
latent structures and measure the same traits as the original Dutch 
4DSQ. Therefore, the French 4DSQ scores convey the same meaning 
as the Dutch scores and the scales can use the same set of cut-off 
points. In this way, the same clinical decisions are reached.
Limitations
Population selection was done in two different ways: the majority 
of the patients (n  = 179) were recruited consecutively in order to 
obtain a representative group from GPs’ consulting patients. The 
other group of patients was recruited with a specific purpose, in 
order to be representative of the patients consulting for one of the 
four dimensions explored by the questionnaire.
Patients’ sociodemographic data, other than gender and age, 
were not available, and we cannot check their representativeness. 
However, the chosen statistical analysis method does not require 
those data for the questionnaire validation.
Incomplete questionnaires were also analysed, using imputation; 
however, the completion rate was very good (99.5%).
The DIF encountered in 13 items did not have a substantial 
impact on the ‘test functioning’. Only three of these items, all related 
to anxiety, were identified both by M–H and OLR methods.
French patients tended to underscore their level of anxiety espe-
cially when the (true) level of anxiety was high. This applies also to 
the way French patients score their level of depression. At the same 
time French patients tended to overscore their level of somatization, 
but only to a very small degree.
It is interesting to note that in English, Polish, as well as French 
translations, there is a DIF for the same anxiety item no.  27. 
‘Angoissé’ (F) and ‘Wystraszony’ (PL) were apparently less severe 
than ‘angstig’ (NL), but ‘frightened’ (EN) appeared to be more severe 
(5,6). Some assumptions can be made to explain those differences: 
even when translations are close to the original meaning they can 
remain linguistically imperfect, especially when one word covers a 
wide range of meanings and strong subjective interpretation. We can 
also hypothesize that there are some cultural differences in meaning 
and that an exact equivalent is not always possible. In French, this 
Table  1. Results of the multigroup CFA, assessing configural 
invariance of one-factor models per 4DSQ scale
4DSQ scale CFI TLI RMSEA 95% CI
Distressa 0.997 0.996 0.046 0.035–0.057
Depression 1.000 0.999 0.042 0.000–0.077
Anxiety 1.000 1.002 0.000 0.000–0.019
Somatizationb 0.990 0.988 0.046 0.035–0.057
CFI, comparative fit index; CI, confidence interval; RMSEA, root mean 
square error of approximation; TLI, Tucker–Lewis index.
aCorrelated residual variance item pairs 47–48 (upsetting events) and 
20–39 (sleep).
bCorrelated residual variance of item pairs 15–16 (thoracic symptoms), 
12–13 (gastrointestinal symptoms) and item triplet 2–4–5 (musculoskeletal 
symptoms).
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term has a broad and emphatic meaning, covering both body con-
cerns and psychological feelings. This kind of variability is explored 
in a European study about depression and multi-morbidity (16).
Despite the fact that some translated items turned out to function 
differently from the original items, the scale scores of the translated 
French 4DSQ function in largely the same way as in the original 4DSQ.
Use of the 4DSQ in French practice
In France, no questionnaire has yet been validated for depression 
and anxiety. As it is the second most frequent chronic disease seen in 
primary care (16), it is important to have a first draft for considera-
tion on the 4DSQ. Indeed, this questionnaire is widely and success-
fully used in the Netherlands.
Other international depression scales have been developed and 
validated for primary care (17), but those questionnaires are only 
able to sort anxiety and depression and do not take into account the 
other dimensions explored in the 4DSQ. And yet, distress and soma-
tization feature in GPs’ consultations to a huge extent: psychological 
problems and medically unexplained symptoms represent >20% of 
consultations (2).
The 4DSQ has the advantage of enabling the GPs to explore those 
issues, which French GPs find particularly difficult to approach, and 
which patients may avoid or deny. A validated tool can improve the 
practice in several ways: it could be used to help the physician in the 
diagnostic process and in the shared decision making. Then, it could 
be a new medium for improving patient–physician communication 
in those sensitive situations. This kind of tool could help to imple-
ment the biopsychosocial model in the practice (18).
Oho-Mpondo Master’s thesis not only showed a good congru-
ence of the depression scale between patients and GPs but also sug-
gested a discrepancy in the evaluation of distress and somatization 
between patients and GPs (19). Those results are consistent with 
Schumacher’s study, which showed a high level of disagreement 
between patients and physicians about medically unexplained symp-
toms (20). This questionnaire could be especially helpful at a denial 
stage of a psychological or psychosomatic problem. Further feasibil-
ity studies could answer this hypothesis.
The primary care system is not organized in the same way in 
the Netherlands as it is in France. In the Netherlands, physicians 
work in a team with an assistant/nurse, whereas they mostly work 
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Figure 1. Item response function curves of two items demonstrating DIF comparing French and Dutch patients. The graphs display the probability of endorsing 
the item response options ‘no’ (coded ‘0’), ‘sometimes’ (coded ‘1’) and ‘regularly’, ‘often’ or ‘very often or constantly’ (coded ‘2’) as a function of the DIF-adjusted 
IRT theta score, which represents an approximation of the ‘true’ somatization or anxiety score. Item 3 (‘fainting’; left panel), belonging to the somatization scale, 
was less severe for French patients than for Dutch patients: French patients endorsed response options ‘1’ and ‘2’ at less severe theta levels than Dutch patients 
did. Item 18 (‘sudden fright for no reason’; right panel), part of the anxiety scale, was more severe for French patients than for Dutch patients: French patients 
endorsed response options ‘1’ and ‘2’ at more severe theta levels than Dutch patients did.
Table 2. Items detected with DIF
Scale Item number Short description (French/English) M–H methoda OLR methodb Directionc
Depression 33 mieux que vous soyez mort/better off if you were dead – 0.025 +
34 rien ne pouvait vous réjouir/you can’t enjoy anything anymore – 0.048 −
Anxiety 18 saisissement soudain/sudden fright for no reason –0.10 0.055 −
21 sensation indéfinissable de peur/a vague feeling of fear – 0.027 −
24 soudaine panique ou forte anxiété/anxiety or panic attacks +0.15 0.023 +
27 Angoissé/Frightened +0.18 0.021 +
45 menacé(e) par un danger inconnu/being threatened by unknown 
danger
– 0.030 −
49 dû éviter certains endroits/have to avoid certain places – 0.039 −
Somatization 1 des vertiges ou la tête qui tourne/dizziness or feeling light-headed −0.12 – −
2 des douleurs musculaires/painful muscles +0.25 – +
3 des malaises/fainting – 0.063 +
4 une douleur dans le cou/neck pain +0.19 – +
9 une sensation de ballonnement/a bloated feeling in the abdomen +0.21 – +
aM–H method: standardized mean differences.
bOLR method: R2 differences.
cDirection of DIF: + the item is less severe for French patients; − the item is more severe for French patients.
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alone in France. Oho-Mpondo suggested that this could hinder the 
use of the 4DSQ in France. Data collection was laborious and it 
was suggested that GPs had difficulty in adopting and using this 
tool in their own practice. Furthermore, the way the questionnaire 
would be presented to French GPs and their patients would have 
to be clarified.
Further studies are needed to evaluate the routine use of the 
4DSQ in primary care in France, and whether this tool would add 
value to the consultation. If so, we could follow the Dutch GPs and 
include 4DSQ to the initial medical training program.
Finally, the validation of the reliability of the 4DSQ in several 
languages opens the way to further collaborative European studies.
Conclusion
The French 4DSQ measures the same constructs (distress, depres-
sion, anxiety and somatization) as the original Dutch 4DSQ, in 
practically the same way. The French scores can be interpreted in 
exactly the same way as the Dutch scores. French GPs’ patients filled 
in the 4DSQ in the same way as Dutch GPs’ patients. Accordingly, 
the French 4DSQ could be used in French General Practice. It could 
be useful in teaching activities for students and former medical edu-
cation. It could also be of help for international collaborative studies 
including French-speaking countries.
Declaration
Funding: none.
Ethical approval: none. 
Conflict of interest: BT is the copyright owner of the 4DSQ and 
receives copyright fees from companies that use the 4DSQ on a com-
mercial basis (the 4DSQ is freely available for non-commercial use 
in health care and research). BT received fees from various institu-
tions for workshops on the application of the 4DSQ in primary care 
settings. JC, J-YLR, PN, HM, JO-M and A-ES declare no conflict of 
interest.
Acknowledgements
The authors would like to thank Drs Frank Raymond, Sylvie Fuger (Ste 
Croix aux mines, France), Marc Bouché (Muntzenheim, France), Hui Zhang 
(Strasbourg, France), Magalie Pfeffer (Ribeauvillé, France) and Pascal Audren, 
Joel le Roch, Lise Le Roch and Emilie Beck Robert (Lanmeur, France) for 
inviting patients, waiting for a consultation, to participate in the study and 
Anne Kervern (trainee in GP) who supervised the data collection in Lanmeur.
References
 1. Shvartzman P, Weiner Z, Vardy D et  al. Health services utilization by 
depressive patients identified by the MINI questionnaire in a primary care 
setting. Scand J Prim Health Care 2005; 23: 18–25.
 2. Verhaak PF, Hoeymans N, Garssen AA, Westert GP. Mental health in the 
Dutch population and in general practice: 1987-2001. Br J Gen Pract 
2005; 55: 770–5.
 3. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report 
version of PRIME-MD: the PHQ primary care study. Primary Care Evalu-
ation of Mental Disorders. Patient Health Questionnaire. JAMA 1999; 
282: 1737–44.
 4. Terluin B, van Marwijk HWJ, Adèr HJ et al. The Four-Dimensional Symp-
tom Questionnaire (4DSQ): a validation study of a multidimensional self-
report questionnaire to assess distress, depression, anxiety and somatiza-
tion. BMC Psychiatry 2006; 6: 34.
 5. Czachowski S, Terluin B, Izdebski A, Izdebski P. Evaluating the cross-
cultural validity of the Polish version of the Four-Dimensional Symptom 
Questionnaire (4DSQ) using differential item functioning (DIF) analysis. 
Fam Pract 2012; 29: 609–15.
 6. Terluin B, Smits N, Miedema B. The English version of the four-dimen-
sional symptom questionnaire (4DSQ) measures the same as the original 
Dutch questionnaire: a validation study. Eur J Gen Pract 2014; 20: 320–6. 
doi:10.3109/13814788.2014.905826.
 7. Van Ginkel J, van der Ark L. SPSS syntax for missing value imputation in 
test and questionnaire data. Appl Psychol Meas 2005; 29: 152–3.
 8. Rosseel Y. Iavaan: an R package for structural equation modeling. J Stat 
Softw 2012; 48: 1–36.
 9. Hu L, Bentler P. Cutoff criteria for fit indexes in covariance structure anal-
ysis: conventional criteria versus new alternatives. Struct Equ Model 1999; 
6: 1–55.
 10. Petersen MA, Groenvold M, Bjorner JB et al. Use of differential item func-
tioning analysis to assess the equivalence of translations of a questionnaire. 
Qual Life Res Int J Qual Life Asp Treat Care Rehabil 2003; 12: 373–85.
 11. Zumbo B. A Handbook on the Theory and Methods of Differential Item 
Functioning (DIF): Logistic Regression Modeling as a Unitary Frame-
work for Binary and Likert-Type (Ordinal) Item Scores. Ottawa, Ontario, 
Depression
12
10
8
6
4
2
0
S
um
 s
co
re
S
um
 s
co
re
S
um
 s
co
re
24
20
16
12
8
4
0
32
28
8
4
0
18
20
24
12
0  1  2  3  4  5-1-5 -4 -3 -2
Theta score
Anxiety
Somatization
French
Dutch
Figure 2. Impact of DIF on the raw scale scores for depression (upper panel), 
anxiety (middle panel) and somatization (lower panel) comparing French and 
Dutch patients. The graphs display the raw scale score as a function of the DIF-
adjusted Rasch theta score, which represents an approximation of the ‘true’ 
depression, anxiety or somatization score. The vertical distance between the 
group-specific curves represents the scale impact of DIF: at higher levels of 
depression and anxiety French patients tended to score a little lower than 
Dutch patients with the same true levels of depression and anxiety did.
4DSQ with DIF analysis 479
Canada: Directorate of Human Resources Research and Evaluation, 
Department of National Defense, 1999.
 12. Hambleton RK. Good practices for identifying differential item function-
ing. Med Care 2006; 44: S182–8.
 13. Michaelides M. An illustration of a Mantel-Haenszel procedure to flag mis-
behaving common items in test equating. Pract Assess Res Eval 2008; 13: 
1–16.
 14. Gotzmann A, Bahry L. Review of “jMetrik.” Res Pract Assess 2012; 7: 56–8.
 15. Choi SW, Gibbons LE, Crane PK. lordif: an R package for detecting differ-
ential item functioning using iterative hybrid ordinal logistic regression/item 
response theory and Monte Carlo simulations. J Stat Softw 2011; 39: 1–30.
 16. Violán C, Foguet-Boreu Q, Hermosilla-Pérez E et al. Comparison of the 
information provided by electronic health records data and a population 
health survey to estimate prevalence of selected health conditions and mul-
timorbidity. BMC Public Health 2013; 13: 251.
 17. Nabbe P, Le Reste JY, Robert E et  al. Family Practice Depression and 
Multi-morbidity (FPDM): a European consensus on a diagnostic depres-
sion tool in primary care. Eur J Gen Pract 2013; 19: 162–84.
 18. Terluin B, Terluin M, Prince K, van Marwijk HWJ. De Vierdimensionale 
Klachtenlijst (4DKL) spoort psychische problemen op. [The Four-Dimen-
sional Symptom Questionnaire (4DSQ) detects psychological problems.] 
Huisarts Wet 2008; 51: 251–5 [English translation available on: www.
emgo.nl/researchtools/4dsq.asp, accessed on 24 April 2015].
 19. Oho Koum-Mpndo J. Exploration des troubles psychosomatiques en 
médecine générale. Apport de l’index des plaintes en quatre dimensions 
(IP4D), questionnaire en cours de validation en langue française. Disserta-
tion. Faculté de Médecine, University of Strasbourg, 2013.
 20. Schumacher S, Rief W, Brähler E et  al. Disagreement in doctor’s and 
patient’s rating about medically unexplained symptoms and health care 
use. Int J Behav Med 2013; 20: 30–7.
